Skip to main content

Table 1 Indication for ECLS support comparing in house implantation (Home) vs. external implantations (Transport)

From: ECLS supported transport of ICU patients: does out-of -house implantation impact survival?

Indication for ECLS all Home Transport p
Total 978 (100) 733 243  
Pneumonia 292 (30) 189 (26) 102 (42) p < 0.001
Influenca A 48 (5) 30 (4) 18 (7) p = 0.32
ARDS 425 (44) 286 (39) 138 (57) p = < 0.001
Lungfibrosis 33 (3) 30 (4) 3 (1) p = 0.038
Pulmonary hypertension 43 (4) 35 (5) 8 (3) p = 0.216
Cystic fibrosis 29 (3) 25 (3) 4 (2) p = 0.373
Lung embolia 50 (5) 39 (5) 11 (5) p = 0.384
PMR/VSD/ASD 29 (3) 19 (3) 10 (4) p = 0.160
Myocardial infarction (NSTEMI, STEMI) 118 (12) 83 (11) 35 (14) p = 0.212
DCM 80 (8) 64 (9) 15 (6) p = 0.224
Myocarditis 26 (3) 15 (2) 11 (5) p = 0.062
Peripartum cardiomyopathy 5 (0.5) 2 (0.3) 3 (1) p = 0.224
Polytrauma 21 (2) 13 (2) 8 (3) p = 0.102
Sepsis 49 (5) 49 (7) 0 p < 0.001
post DLTX 30 (3) 30 (4) 0 p < 0.001
Postcardiectomie 2 (0.2) 2 (0.3) 1 (0.4) p = 0.564
Burn 16 (2) 16 (2) 0 p = 0.410
Post HTX 20 (2) 20 (3) 4 (2) p = 0.006
Cardiac failure after VAD 34 (4) 33 (5) 1 (0.4) p = 0.001
Postcardiotomie 109 (11) 108 (15) 1 (0.4) p < 0.001
Others 92 (9) 83 (11) 9 (4) p < 0.001
  1. ARDS: acute respiratory distress syndrome, PMR: Papillary muscle rupture, VSD: ventricular septum defect, ASD: atrial septum defect